Boston Partners lowered its stake in shares of Maximus, Inc. (NYSE:MMS – Free Report) by 18.1% during the third quarter, Holdings Channel reports. The fund owned 745,262 shares of the health services provider’s stock after selling 164,778 shares during the quarter. Boston Partners’ holdings in Maximus were worth $39,775,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in MMS. BlackRock Inc. acquired a new stake in shares of Maximus during the 2nd quarter worth about $400,186,000. Dimensional Fund Advisors LP raised its position in shares of Maximus by 7.2% in the first quarter. Dimensional Fund Advisors LP now owns 2,107,278 shares of the health services provider’s stock valued at $135,084,000 after buying an additional 141,362 shares during the last quarter. Reinhart Partners LLC. raised its position in shares of Maximus by 131.8% in the second quarter. Reinhart Partners LLC. now owns 1,982,415 shares of the health services provider’s stock valued at $106,575,000 after buying an additional 1,127,346 shares during the last quarter. Stephens Investment Management Group LLC raised its position in shares of Maximus by 0.5% in the third quarter. Stephens Investment Management Group LLC now owns 859,320 shares of the health services provider’s stock valued at $45,707,000 after buying an additional 4,535 shares during the last quarter. Finally, Bank of America Corp DE purchased a new position in shares of Maximus during the second quarter valued at approximately $31,487,000. Hedge funds and other institutional investors own 97.21% of the company’s stock.
Wall Street Analyst Weigh In
MMS has been the topic of a number of analyst reports. Wall Street Zen upgraded shares of Maximus from a “hold” rating to a “buy” rating in a research report on Saturday. Zacks Research raised shares of Maximus from a “strong sell” rating to a “hold” rating in a research note on Thursday, October 1st. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Maximus in a research report on Friday, November 13th. Two investment analysts have rated the stock with a Hold rating. According to MarketBeat, the stock currently has a consensus rating of “Hold”.
Maximus News Summary
Here’s some of the latest news about MMS:
- Positive Sentiment: Fiscal Q4 adjusted earnings were $2.11 per share, above consensus estimates of roughly $1.85–$1.88 and up from $1.62 a year earlier. Revenue of $1.30 billion was in line with estimates. Maximus tops Q4 earnings estimates
- Positive Sentiment: Management forecast fiscal 2027 revenue of $5.5 billion–$5.7 billion, above the cited $5.4 billion analyst consensus, and free cash flow of $700 million–$800 million while integrating Agile Defense. Maximus forecasts fiscal 2027 free cash flow
- Negative Sentiment: Quarterly revenue fell 1.3% year over year, and reports noted the shares had slipped below their 200-day moving average, highlighting concerns about near-term momentum. Maximus stock breaks below its 200-day moving average
Maximus Stock Up 1.0%
Shares of NYSE:MMS opened at $62.64 on Friday. The firm has a market cap of $3.28 billion, a PE ratio of 8.60 and a beta of 0.57. The company has a fifty day simple moving average of $60.19 and a 200 day simple moving average of $62.81. The company has a current ratio of 2.42, a quick ratio of 2.42 and a debt-to-equity ratio of 0.90. Maximus, Inc. has a 12-month low of $51.04 and a 12-month high of $100.00.
Maximus (NYSE:MMS – Get Free Report) last announced its quarterly earnings data on Thursday, November 19th. The health services provider reported $2.11 earnings per share for the quarter, topping the consensus estimate of $1.85 by $0.26. The company had revenue of $1.30 billion during the quarter, compared to analyst estimates of $1.30 billion. Maximus had a net margin of 7.07% and a return on equity of 24.91%. The firm’s revenue for the quarter was down 1.3% compared to the same quarter last year. During the same period last year, the business earned $1.62 EPS. Maximus has set its FY 2027 guidance at 7.500-8.000 EPS. On average, equities research analysts anticipate that Maximus, Inc. will post 7.95 EPS for the current fiscal year.
Maximus Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Monday, November 30th. Stockholders of record on Friday, November 13th will be given a dividend of $0.33 per share. The ex-dividend date of this dividend is Friday, November 13th. This represents a $1.32 annualized dividend and a dividend yield of 2.1%. Maximus’s dividend payout ratio (DPR) is presently 19.50%.
Insider Buying and Selling
In related news, insider Michelle Link sold 3,208 shares of Maximus stock in a transaction dated Thursday, October 1st. The stock was sold at an average price of $54.23, for a total value of $173,969.84. Following the completion of the transaction, the insider directly owned 13,881 shares in the company, valued at approximately $752,766.63. This trade represents a 18.77% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 1.80% of the company’s stock.
About Maximus
Maximus, Inc. provides technology-enabled services to government agencies, helping them administer public programs and deliver services to residents. Its work includes managing contact centers, processing applications and eligibility determinations, conducting health assessments, and supporting appeals and other case-management functions. The company serves clients in the United States and internationally, including government agencies in the United Kingdom, Canada and Australia. Its services span health and human services programs as well as federal government operations, with technology and digital services supporting its program work.
Further Reading
- Five stocks we like better than Maximus
- Survey Reveals: How Much Would People Pay for Ribeye Before Giving It Up? [2026]
- If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel It
- 3 Dividend ETFs Offering Steadier Footing in a Shaky Market
- Lazard’s New ETF Targets Monthly Income With Junk Bonds
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS – Free Report).
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.
